Oncology & Cancer

Study shows fit elderly patients should be considered for therapy

Until there are more validated biomarkers to direct treatment decisions, many physicians use patient age to decide what therapy to give their patients. Literature data report that older patients often go undertreated because ...

Oncology & Cancer

Abraxane approved to treat advanced lung cancer

(HealthDay)—Abraxane (paclitaxel protein-bound) has been approved by the U.S. Food and Drug Administration—in combination with the drug carboplatin—to treat advanced or spreading non-small cell lung cancer among people ...

Oncology & Cancer

No therapy for 20 percent with stage IV solid tumors

(HealthDay) -- About 20 percent of patients diagnosed with stage IV metastatic solid tumors do not receive anticancer treatment, according to a study published online June 15 in Cancer.

Oncology & Cancer

Targeted radiation for lung cancer may carry risks

(HealthDay) -- A woman with early-stage lung cancer died recently after highly targeted radiation therapy zapped not just her tumor, but surrounding tissue, fatally damaging her airway.

Diabetes

Diabetes linked to lung cancer in postmenopausal women

(HealthDay) -- Postmenopausal women with diabetes are at a significantly higher risk of developing lung cancer, particularly if they require insulin therapy, according to research published online May 22 in Diabetes Care.

page 20 from 24